Technology that offers tools that conform, de-identify, link and aggregate data and data science tools like AI, machine learning and advanced analytics, can help those researching rare diseases overcome the hurdles they face in discovery and development. The post Data Technology + RWD Are Positive for Rare Disease Treatment appeared first on MedCity News.
Certify’s $40 million round was led by Transformation Capital, and included support from General Catalyst, Upfront Ventures and SemperVirens. The post Certify Raises $40M To Advance Healthcare Provider Data Infrastructure appeared first on MedCity News.
Vor Bio is licensing global rights a fusion protein that inhibits two targets to potentially treat the neuromuscular disorder generalized myasthenia gravis. It’s a pivot for Vor, which last month ceased its cancer R&D and announced it would explore strategic alternatives. The post Vor Bio Reinvents Itself as an Autoimmune Biotech With In-Licensed Phase 3…
There is no singular cause to pediatrician burnout. Rather, it’s a web of interconnected issues, compounded and feeding upon each other. And if we want to truly support pediatricians and the children they care for, we need to stop treating symptoms and start untangling the root causes. The post From Burnout to Breakthrough: Reinventing Pediatric…
The widespread investment in AI furthers economists’ optimism about a “roaring 20’s” of worker productivity on the horizon. However, this will not take place in health care without accompanying systemic and organizational actions that rethink what we financially incentivize, how we integrate new technologies, how we shift tasks, and how we prepare the workforce. The…
Two digital health companies have gone public this year: Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech in the public markets. The post What VCs Have Learned About Health Tech in the Public Markets appeared first on MedCity News.
EnsoData raised $20 million in Series B funds for its AI-powered sleep diagnostics. The company’s technology aims to help clinicians diagnose sleep disorders faster and more consistently. The post EnsoData Snags $20M to Improve Sleep Disorder Diagnostics appeared first on MedCity News.
Novavax’s partnership with Sanofi allows the pharma giant to explore potential combinations of assets from both companies, and it’s a blueprint for the kinds of alliances the vaccine developer is pursuing. Rather than commercializing vaccines, Novavax aims to turn its research into business development deals, R&D executive Ruxandra Draghia-Akli said. The post Novavax Sees Sanofi…
There are two changes that could transform the entire system. If we can do these two things, the entire market improves. Not everyone will win, but the good products, the good distributors and the good platforms will rise to the top. The post How More Competition and Better Connected Data Will Solve Healthcare’s Billion Dollar…
To any father that’s struggling right now, know this: your past doesn’t have to write your future. Help is out there, and you can change the trajectory of your life and that of your family. The post A Father’s Promise: Breaking the Cycle of Trauma and Addiction for My Son appeared first on MedCity News.